Hoon Ryu, PhD

Adjunct Associate Professor, Neurology

Hoon Ryu
857.364.5910
150 S Huntington Avenue

Biography

Dr. Hoon Ryu earned his doctoral degree from Chonbuk National University, South Korea. He completed a postdoctoral research fellowship and was appointed Instructor of Neurology at Beth Israel Deaconess Medical Center and Harvard Medical School in 1999. He joined the Chobanian and Avedisian School of Medicine’s Department of Neurology in 2004 as an Assistant Professor. Now he is an Associate Professor and an investigator with the Boston University Alzheimer’s Disease Center and VA Boston Healthcare System. He is a director of the laboratory for Neuronal Gene Regulation and Epigenetics. He works on the identification of biomarkers, the determination of molecular genetic, epigenetic mechanisms, and the development of therapeutics using cell culture systems and animal models of neurodegeneration. He has published over 70 original reports.

Research Interests:

Epigenetic changes encompass an array of molecular modifications including DNA methylation and changes to the chromatin packaging of DNA by post-translational histone modifications. The structure, dynamics, and chemical properties of chromatin almost completely determines how, when, and which genes are turned on and off. Chromatin remodeling and transcription regulation are tightly controlled under physiological conditions. Deregulation of chromatin remodeling is linked to the pathogenesis of neurodegenerative disorders but the mechanism is elusive. In order to identify how genomes are deregulated by heterochromatin, Dr. Ryu is performing ChIP genome-wide sequencing combined with RNA-sequencing followed by platform integration analysis. He has found that altered chromatin plasticity is closely linked to the pathogenesis of Huntington’s disease via an expression of ESET (ERG-associated protein with a SET domain), a histone H3K9-specific methyltransferase. Currently, he is conducting research about mechanisms of ESET gene induction and neuronal heterochromatin condensation in Alzheimer’s disease.

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
  • VA Boston Healthcare System

Websites

Education

  • Chonbuk National University, PhD
  • Chonbuk National University, MS
  • Chonbuk National University, BS

Publications

  • Published on 5/3/2024

    Kim D, Ko HY, Chung JI, Park YM, Lee S, Kim SY, Kim J, Chun JH, Han KS, Lee M, Ju YH, Park SJ, Park KD, Nam MH, Kim SH, Shim JK, Park Y, Lim H, Park J, Lee GH, Kim H, Kim S, Park U, Ryu H, Lee SY, Park S, Kang SG, Chang JH, Lee CJ, Yun M. Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment. Neuro Oncol. 2024 May 03; 26(5):843-857. PMID: 38085571.

    Read at: PubMed
  • Published on 5/2/2024

    Kang JH, Yoon T, Lee C, Lim S, Ryu H. Design of high-performance entangling logic in silicon quantum dot systems with Bayesian optimization. Sci Rep. 2024 May 02; 14(1):10080. PMID: 38698015.

    Read at: PubMed
  • Published on 4/15/2024

    Cho A, Oh SY, Lee H, Ryu HG. VASOPRESSOR REDUCTION EFFECT OF POLYMYXIN B HEMOPERFUSION IN PATIENTS WITH PERITONITIS-INDUCED SEPTIC SHOCK: A PROPENSITY SCORE-MATCHED ANALYSIS. Shock. 2024 Jul 01; 62(1):69-73. PMID: 38661146.

    Read at: PubMed
  • Published on 4/6/2024

    Lim L, Park SJ, Kang C, Oh SY, Ryu HG, Lee H. Perioperative urinary ketosis and metabolic acidosis in patients fasted for undergoing gynecologic surgery. Acta Anaesthesiol Scand. 2024 Apr 06. PMID: 38581223.

    Read at: PubMed
  • Published on 3/15/2024

    Kim DK, Choi H, Lee W, Choi H, Hong SB, Jeong JH, Han J, Han JW, Ryu H, Kim JI, Mook-Jung I. Brain hypothyroidism silences the immune response of microglia in Alzheimer's disease animal model. Sci Adv. 2024 Mar 15; 10(11):eadi1863. PMID: 38489366.

    Read at: PubMed
  • Published on 3/14/2024

    Kang YJ, Hyeon SJ, McQuade A, Lim J, Baek SH, Diep YN, Do KV, Jeon Y, Jo DG, Lee CJ, Blurton-Jones M, Ryu H, Cho H. Neurotoxic Microglial Activation via IFN?-Induced Nrf2 Reduction Exacerbating Alzheimer's Disease. Adv Sci (Weinh). 2024 May; 11(20):e2304357. PMID: 38482922.

    Read at: PubMed
  • Published on 2/22/2024

    Bhusal A, Kim JH, Kim SC, Hwang EM, Ryu H, Ali MS, Park SC, Lee WH, Suk K. The microglial innate immune protein PGLYRP1 mediates neuroinflammation and consequent behavioral changes. Cell Rep. 2024 Mar 26; 43(3):113813. PMID: 38393947.

    Read at: PubMed
  • Published on 1/1/2024

    Oh SY, Woo HY, Lim L, Im H, Lee H, Lee JM, Hong SK, Choi Y, Yi NJ, Lee KW, Suh KS, Ryu HG. Comparison of postoperative ascites replacement strategies on time to first flatus after living donor liver transplantation: Albumin vs. lactated Ringer's solution. Clin Transplant. 2024 Jan; 38(1):e15231. PMID: 38289882.

    Read at: PubMed
  • Published on 10/1/2023

    Heo JY, Park AH, Lee MJ, Ryu MJ, Kim YK, Jang YS, Kim SJ, Shin SY, Son HJ, Stein TD, Huh YH, Chung SK, Choi SY, Kim JM, Hwang O, Shong M, Hyeon SJ, Lee J, Ryu H, Kim D, Kweon GR. Correction: Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism. Mol Psychiatry. 2023 Oct; 28(10):4485. PMID: 37783789.

    Read at: PubMed
  • Published on 9/14/2023

    Jung JW, Kim H, Park J, Woo J, Jeon E, Lee G, Park M, Kim S, Seo H, Cheon S, Dan K, Lee J, Ryu H, Han D. In-depth proteome analysis of brain tissue from Ewsr1 knockout mouse by multiplexed isobaric tandem mass tag labeling. Sci Rep. 2023 Sep 14; 13(1):15261. PMID: 37709831.

    Read at: PubMed

View 159 more publications: View full profile at BUMC

View all profiles